These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 16207894)

  • 1. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
    Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
    Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a MUC1-based cancer vaccine.
    Hanisch FG
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):705-8. PubMed ID: 16042579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.
    Stepensky D; Tzehoval E; Vadai E; Eisenbach L
    Clin Exp Immunol; 2006 Jan; 143(1):139-49. PubMed ID: 16367945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.
    Pett C; Cai H; Liu J; Palitzsch B; Schorlemer M; Hartmann S; Stergiou N; Lu M; Kunz H; Schmitt E; Westerlind U
    Chemistry; 2017 Mar; 23(16):3875-3884. PubMed ID: 27957769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
    Galli-Stampino L; Meinjohanns E; Frische K; Meldal M; Jensen T; Werdelin O; Mouritsen S
    Cancer Res; 1997 Aug; 57(15):3214-22. PubMed ID: 9242452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.
    Ryan SO; Vlad AM; Islam K; Gariépy J; Finn OJ
    Biol Chem; 2009 Jul; 390(7):611-8. PubMed ID: 19426130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
    Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic glycopeptides for the development of cancer vaccines.
    Liakatos A; Kunz H
    Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.
    Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M
    Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
    Dziadek S; Kunz H
    Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
    Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
    Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorinated glycosyl amino acids for mucin-like glycopeptide antigen analogues.
    Wagner S; Mersch C; Hoffmann-Röder A
    Chemistry; 2010 Jun; 16(24):7319-30. PubMed ID: 20461825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines.
    Xiao A; Zheng XJ; Song C; Gui Y; Huo CX; Ye XS
    Org Biomol Chem; 2016 Jul; 14(30):7226-37. PubMed ID: 27380866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.
    Dziadek S; Hobel A; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2005 Nov; 44(46):7630-5. PubMed ID: 16247815
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.
    Wu X; McKay C; Pett C; Yu J; Schorlemer M; Ramadan S; Lang S; Behren S; Westerlind U; Finn MG; Huang X
    ACS Chem Biol; 2019 Oct; 14(10):2176-2184. PubMed ID: 31498587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.